Hyperbaric Oxygen and Ginkgo Biloba Extract Inhibit Aβ25-35-induced Toxicity and Oxidative Stress in vivo: A Potential Role in Alzheimer's Disease

REFERENCES

• Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol. 2000;60:139–65.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Chauhan A. Oxidative stress in Alzheimer's disease. Pathophysiology. 2006;13:195–208.
   PubMedGoogle Scholar
• Combs CK, Karlo JC, Kao SC, Landreth GE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci. 2001;21:1179–88.
   PubMed Web of Science ®Google Scholar
• Reddy PH. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Experimental Neurology. 2009;218:286–92.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Siciliano R, Barone E, Preziosi P. Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine. Biochim Biophys Acta. 2012;1822:616–24.
   PubMed Web of Science ®Google Scholar
• Smith J, Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGB 761. J Alzheimer's Dis. 2003;5:287–300.
   PubMed Web of Science ®Google Scholar
• Hoerr R. Behavioural and psychological symptoms of dementia (BPSD): Effects of EGb 761. Pharmacopsychiatry. 2003;36(Suppl1):S56–61.
   PubMed Web of Science ®Google Scholar
• MortensenCR. Hyperbaric oxygen therapy. Current Anaesthesia & Critical Care. 2008;19:333–37.
   Google Scholar
• Nemoto EM, Betterman K. Basic physiology of hyperbaric oxygen in brain. Neurol Res. 2007;29:116–26.
   PubMed Web of Science ®Google Scholar
• Wang YC, Zhang S, Du TY, Wang B, Sun XQ. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by stimulating autophagy in neurocyte. Brain Research. 2010;1323:149–51.
   PubMed Web of Science ®Google Scholar
• Wang GH, Zhang XG, Jiang ZL, Li X, Peng LL, Li YC. Neuroprotective Effects of Hyperbaric Oxygen Treatment on Traumatic Brain Injury in the Rat. J Neurotrauma. 2010;27:1733–43.
   PubMed Web of Science ®Google Scholar
• Watson C, Paxinos G. The Rat Brain in Stereotaxic Coordinates, U.S.: Academic Press; 2000.
   Google Scholar
• Han HJ, Hui HX, Yang CZ. Dose conversion among different animals and healthy volunteers in pharmacological study. Chin J Clin Pharmacol. 2004;9:1069–72.
   Google Scholar
• Morris R. Developments of a water maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11: 47–60.
   PubMed Web of Science ®Google Scholar
• Kuang X, Du JR, Liu YX, Zhang GY, Peng HY. Postischemic administration of Z-ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats. Pharmacol Biochem Behav. 2008;88:213–21.
   PubMed Web of Science ®Google Scholar
• Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav. 2004;80:647–55.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131–38.
   Web of Science ®Google Scholar
• Tong X, Nicolakakis N, Kocharyan A, Hamel E. Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J Neurosci. 2005;30:11165–74.
   Google Scholar
• Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci. 2007;8:766–75.
   PubMed Web of Science ®Google Scholar
• Limón ID, Díaz A, Mendieta L, Chamorro G, Espinosa B, Zenteno E, Guevara J. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats. Neurosci Res. 2009;63:129–37.
   PubMed Web of Science ®Google Scholar
• Hensley K, Carney JM, Mattson MP. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA. 1994;91:3270–74.
   Web of Science ®Google Scholar
• Yatin SM, Varadarajan S, Butterfield DA. Vitamin E prevents Alzheimer's amyloid b-peptide (1–42)-induced neuronal protein oxidation and reactive oxygen species production. J Alzheimer's Disease. 2000;2:123–31.
   PubMedGoogle Scholar
• Calvert JW, Zhou C, Nanda A, Zhang JH. Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia–ischemia rat model. J Appl Physiol. 2003;95:2072–80.
   PubMed Web of Science ®Google Scholar
• Mahadevan S, Park Y. Multifaceted therapeutic benefits of Ginkgo bilobal: chemistry, efficacy, safety, and uses. J Food Sc. 2008;73:14–19.
   Web of Science ®Google Scholar
• Mahady GB. Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J Cardiovasc Nurs. 2002;16:21–32.
   PubMedGoogle Scholar
• DeFeudis FV, Papadopoulos V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol. 2003;17:405–17.
   PubMed Web of Science ®Google Scholar
• Song W, Guan HJ, Zhu XZ, Chen ZL, Yin ML, Cheng XF. Protective effect of bilobalide against nitric oxide-induced neurotoxicity in PC12 cells. Acta Pharmacol Sin. 2000;21:415–20.
   PubMed Web of Science ®Google Scholar